The Net Margin of Hyloris Pharmaceuticals SA (HYL.BR) is -74.98%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -74.98% |
| 2023-12-31 | -546.55% |
| 2022-12-31 | -403.42% |
| 2021-12-31 | -374.00% |
| 2020-12-31 | -4083.43% |
| 2019-12-31 | -6338.46% |
| 2018-12-31 | -6636.26% |
| 2017-12-31 | -1745.07% |